(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE IMUNOCONJUGADOS DE ANTI-CEACAM5 PARA TRATAR CÂNCERES NEUROENDÓCRINOS QUE EXPRESSAM CEACAM5

Em AnáliseInvention PatentPCT · EP2024055281

Application data

Number

112025018353

Type

Invention Patent

Filing

02/29/2024

Publication

06/30/2026

PCT

EP2024055281

Progress at the INPI

Examination not yet requested
  1. Filing02/29/24
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 02/28/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:02/28/2027(187 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/30/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SANOFI

FR

See this company's full portfolio

Inventors

A. B. (pessoa física)

FR

A. L. (pessoa física)

FR

J. S. (pessoa física)

FR

M. C. (pessoa física)

FR

R. M. (pessoa física)

US

Technical data

IPC Classification

Priority claims

EP

23305267.9 · 03/01/2023

Abstract

USO DE IMUNOCONJUGADOS DE ANTI-CEACAM5 PARA TRATAR CÂNCERES NEUROENDÓCRINOS QUE EXPRESSAM CEACAM5. A presente invenção refere-se a métodos para tratar cânceres neuroendócrinos usando imunoconjugados compreendendo um anticorpo que se liga especificamente a hCEACAM5, em particular a hCEACAM5.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

06/30/2026

RPI 2895

Alteração de dados cadastrais

#1.1

09/09/2025

RPI 2853

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.